Skip to content

The application of APP platform in the self-efficacy of gestational diabetes patients

The application of APP platform in the self-efficacy of gestational diabetes patients

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022341
Enrollment
Unknown
Registered
2019-04-06
Start date
2019-01-01
Completion date
Unknown
Last updated
2019-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gestational diabetes mellitus

Interventions

Experimental group:APP platform
Control group:Routine management

Sponsors

the First Affiliated Hospital of Shantou University Medical College
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
26 Years to 43 Years

Inclusion criteria

Inclusion criteria: Routine OGTT screening at 24-28 weeks of gestation, FPG 5.1mmol/L, 1h PG 10.0mmol/L, 2h PG 8.5mmol/L, and the diagnosis could be confirmed if the blood glucose at any time point was higher than the standard. Clear consciousness, normal mind, Willing to participate in this study.

Exclusion criteria

Exclusion criteria: Patients with diabetes mellitus complicated with pregnancy, those with known abnormal fetus or preterm labor, those with multiple pregnancies, and those with gestational diabetes mellitus in the first pregnancy; Patients with acute complications and various serious heart, brain, lung and kidney diseases; Patients with dysphasia of language communication and patients who cannot take care of themselves.

Design outcomes

Primary

MeasureTime frame
Blood sugar levels;scale;

Countries

China

Contacts

Public ContactWenjuan Ying

The First Affiliated Hospital of Shantou University Medical College

yingwenjuan@126.com+86 139 02729444

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026